Post-COVID-19 convalescence and thromboembolic disease
Keywords:
blood coagulation disorders, covid-19, covid-19 post-acute syndrome, venous thromboembolismAbstract
The letter to the editor “Post-COVID-19 Convalescence”, published in volume 28 (2022), is considered very timely and accurate; expressing that patients recovered from COVID-19 suffer from multiple symptoms that are sequelae of the disease. Thromboembolisms – studied by the specialty of angiology and vascular surgery – are the most frequent, and cause deaths.
Downloads
References
Acosta-Arias Y. Isquemia arterial aguda trombótica pos-COVID-19. Rev Cubana Angiol Cir Vasc [Internet]. Abr 2022 [citado 12 Jul 2022];23(1):e321. Disponible en: http://scielo.sld.cu/pdf/ang/v23n1/1682-0037-ang-23-01-e321.pdf
Benalcázar-Freire JF, Tipantaxi-Flores SS, Benítez-Guerrero MA. SARS-CoV-2 y enfermedad tromboembólica venosa. No todo es nuevo. Angiología [Internet]. Dic 2020 [citado 12 Jul 2022];72(6):286-97. Disponible en: https://scielo.isciii.es/pdf/angiologia/v72n6/0003-3170-angiologia-72-6-286.pdf
Zamora-González Y. Infección por SARS-CoV-2 y sus efectos sobre el sistema de la coagulación. Rev Cubana Hematol Inmunol Hemoter [Internet]. 2020 [citado 23 Jul 2022];36:e1303. Disponible en: https://revhematologia.sld.cu/index.php/hih/article/download/1303/955
Bustillo-Santandreu MDJ, Álvarez-López Y, Feíto-Castex TR, García-Seco F, Montes de Oca-García Y, González-Bustillo EA. Morbi-mortalidad de la enfermedad tromboembólica venosa en el Hospital Universitario “Arnaldo Milián Castro”. Rev Cubana Angiol Cir Vasc [Internet]. Abr 2022 [citado 13 Jul 2022];23(1):e320. Disponible en: http://scielo.sld.cu/pdf/ang/v23n1/1682-0037-ang-23-01-e320.pdf
Moreno G, Carbonell R, Bodí M, Rodríguez A. Revisión sistemática sobre la utilidad pronóstica del dímero-D, coagulación intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID-19. Medicina Intensiva [Internet]. Feb 2021 [citado 12 Jul 2022];45(1):42-55. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298463/pdf/main.pdf
Rosa CM. Dímero D y COVID-19. N Engl J Med [Internet]. 2020 [citado 23 Jul 2022];382:1708-20. Disponible en: https://www.grupocaht.com/wp-content/uploads/2020/10/DD-y-COVID-19-DMT-Set-2020.pdf
Sánchez-Vera N, Saavedra-Hernández D, Hidalgo-Mesa CJ, Águila-López M, Abreu-Gutiérrez G, Herrera-González V, et al. Parámetros de laboratorio clínico en pacientes con la COVID-19. Rev Cub Med Mil [Internet]. Jun 2021 [citado 21 Jul 2022];50(2):e1171. Disponible en: http://scielo.sld.cu/pdf/mil/v50n2/1561-3046-mil-50-02-e1171.pdf
Salinas-Aguirre JE, Sánchez-García C, Rodríguez-Sánchez R, Rodríguez-Muñoz L, Díaz-Castaño A, Bernal-Gómez R. Características clínicas y comorbilidades asociadas a mortalidad en pacientes con COVID-19 en Coahuila (México). Rev Clin Esp [Internet]. May 2022 [citado 21 Jul 2022];222(5):288-92. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816557/pdf/main.pdf
Romero-Nájera DE, Puertas-Santana N, Rivera-Martínez M, Badillo-Alviter G, Rivera-Vázquez P. COVID-19 y enfermedades crónicas, un análisis en México. Rev Médica Universidad Autónoma Sinaloa. Rev Med UAS [Internet]. Mar 2021 [citado 22 Jul 2022];11(1):61-71. Disponible en: https://hospital.uas.edu.mx/revmeduas/articulos/v11/n1/covid19cronicas.pdf
Ravid JD, Leiva O, Chitalia VC. Janus kinase signaling pathway and its role in COVID-19 inflammatory, vascular, and thrombotic manifestations. Cells [Internet]. Ene 2022 [citado 12 Jul 2022];11(2):306. Disponible en: https://www.mdpi.com/2073-4409/11/2/306/pdf
Fernández-Lozano I, Cequier-Fillat A, Expósito-García V, Masjuan-Vallejo J, Roldán-Rabadán I, Freixa-Pamias R, et al. Mejorar la prevención de la trombosis y las complicaciones cardiovasculares durante la pandemia de COVID-19. Rev Esp Cardiol Supl [Internet]. 2021 [citado 12 Jul 2022];l 21:1-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320271/pdf/main.pdf
Piera-Carbonell A, Frías-Vargas M, García-Vallejo O, García-Lerín A, Cabrera-Ferriols MA, Peiró-Morant J, et al. COVID-19 y tromboprofilaxis: recomendaciones para nuestra práctica clínica en Atención Primaria. Med Familia SEMERGEN [Internet]. Oct 2020 [citado 21 Jul 2022];46(7):479-86. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500906/
Llisterri-Caro JL. La maldita pandemia: una oportunidad para la Atención Primaria de Salud. Semergen [Internet]. Abr 2020 [citado 12 Jul 2022];46(3):149-50. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270487/pdf/main.pdf
Acevedo-Peña J, Yomayusa-González N, Cantor-Cruz F, Pinzón-Flórez C, Barrero-Garzón L, De la Hoz-Siegler I, et al. Consenso colombiano para la prevención, el diagnóstico y el tratamiento de condiciones trombóticas en adultos con COVID-19: aplicando el Marco de la Evidencia a la Decisión (EtD) GRADE. Rev. Colomb. Cardiol. [Internet]. Oct 2020 [citado 21 Jul 2022];27(5):446-60. Disponible en: http://www.scielo.org.co/pdf/rcca/v27n5/0120-5633-rcca-27-05-446.pdf
Guillermo-Esposito C, Casais P, Cesarman-Maus G, Andrade-Orsi F, Martínez-Rovira R, De Campos-Guerra JC, et al. Guía de profilaxia y tratamiento antitrombótico para pacientes con COVID-19. Consenso del Grupo Cooperativo Latinoamericano en Hemostasia y Trombosis (CLAHT). Arch. Cardiol. Méx. [Internet]. Dic 2021 [citado 21 Jul 2022];91 Supl 2:47-54. Disponible en: https://www.scielo.org.mx/pdf/acm/v91s2/1405-9940-acm-91-Supl-47.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jesús Tejidor Fernández, Jorge Luis Carrera Martínez, Alejandro González Álvarez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
The journal is not responsible for the opinions and concepts expressed in the works, which are the exclusive responsibility of the authors. The Editor, with the assistance of the Editorial Committee, reserves the right to suggest or request advisable or necessary modifications. Original scientific works are accepted for publication, as are the results of research of interest that have not been published or sent to another journal for the same purpose.
The mention of trademarks of specific equipment, instruments or materials is for identification purposes, and there is no promotional commitment in relation to them, neither by the authors nor by the editor.
